GH–RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells
- 7 March 2003
- journal article
- Published by Elsevier in Life Sciences
- Vol. 72 (22) , 2473-2479
- https://doi.org/10.1016/s0024-3205(03)00164-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Induction of Vascular Endothelial Growth Factor by IGF-I in Osteoblast-Like Cells Is Mediated by the PI3K Signaling Pathway through the Hypoxia-Inducible Factor-2αEndocrinology, 2002
- Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormoneAnti-Cancer Drugs, 2001
- Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisNature, 1998
- Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective StudyScience, 1998
- Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patientsBritish Journal of Cancer, 1997
- Somatostatin and Growth Hormone-Releasing Hormone in Normal and Tumoral Human Breast Tissue: Endogenous Content, in Vitro Pulsatile Release, and RegulationJournal of Clinical Endocrinology & Metabolism, 1997
- Role of soluble mediators in angiogenesisEuropean Journal Of Cancer, 1996
- Vascular endothelial growth factorEuropean Journal Of Cancer, 1996
- A SV‐40 immortalized murine endothelial cell line from peripheral lymph node high endothelium expresses a new α‐L‐fucose binding proteinBiology of the Cell, 1993
- Distribution of Immunoreactive Growth Hormone-Releasing Hormone in the Human Brain and Intestine and Its Production by Tumors*Journal of Clinical Endocrinology & Metabolism, 1984